Hepatitis B and C are viruses that infect the liver and can silently progress to become serious diseases such as cirrhosis and liver cancer. Effective antiviral treatment is available and timely treatment of eligible patients can prevent hepatitis-related burden of disease and death. The main...

Dublin Declaration reporting does not attempt to define migrants, as countries use the term migrants in different ways. In the context of HIV, countries refer to three main groups: migrants from countries with generalised HIV epidemics; migrants who are part of particular sub-populations at...

This report presents the published evidence of sexual transmission of HIV among populations from countries with generalised HIV epidemics in the European Union/European Economic Area (EU/EEA). Member states' surveillance systems for monitoring the sexual transmission of HIV in the EU/EEA among...

In April 2011, upon request from the Greek Ministry of Health and Social Solidarity, a joint ECDC/WHO Regional Office for Europe mission was undertaken to Greece to assess the situation related to the increased migration at the Greek-Turkish border. The objective of the mission was to assist...

Hepatitis B and C are viruses that infect the liver and can silently progress to become serious diseases such as cirrhosis and liver cancer. Effective antiviral treatment is available and timely treatment of eligible patients can prevent hepatitis-related burden of disease and death. The main...

In recent years, migrants have accounted for more than 40% of new HIV diagnoses in the EU/EEA. Migrants living with HIV can face numerous intersecting stigmas related to their HIV and migration status, as well as broader racial and cultural discrimination. For the purposes of this report,...

- The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review; - Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015.